FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051557900> ?p ?o ?g. }

• W2051557900 endingPage "696" @default.
• W2051557900 startingPage "691" @default.
• W2051557900 abstract "Study Objectives. To characterize the safety of concomitant aspirin, clopidogrel, and warfarin therapy after percutaneous coronary intervention (PCI), and to identify patient characteristics that increase the risk of hemorrhage. Design. Retrospective, matched cohort study. Setting. Academic medical center and affiliated outpatient offices. Patients. The active group consisted of 97 patients who underwent PCI from January 1, 2000–September 30, 2005, and received warfarin, aspirin, and clopidogrel; the control group consisted of 97 patients who were individually matched to patients in the active group by procedure type, procedure year, age, and sex. Control patients received aspirin and clopidogrel. Measurements and Main Results. Clinical data were collected from inpatient records, outpatient physician office records, and telephone surveys administered to patients or caregivers. The primary end point was major bleeding. The median duration of follow-up after index procedure was 182 days (range 0–191 days) in the active group and 182 days (range 0–213 days) in the control group. Fifty-seven (59%) of the 97 patients in the active group received warfarin for atrial fibrillation. There were 14 major bleeds in the active group (including 1 death) and 3 major bleeds in the control group during the study period. Mean international normalized ratio at the time of bleeding was 3.4. Hazard ratio for major bleeding was 5.0 in patients receiving warfarin therapy (95% confidence interval 1.4–17.8, p=0.012). Aspirin dose, age, sex, body mass index, history of hypertension, diabetes mellitus, intraprocedural glycoprotein IIb-IIIa or anticoagulant type, and postprocedural anticoagulant use did not have a significant effect on the risk of major bleeding. Conclusion. Warfarin was an independent predictor of major bleeding after PCI in patients receiving dual antiplatelet therapy. Prospective data to further characterize the safety of concomitant warfarin and dual antiplatelet therapy after PCI are needed." @default.
• W2051557900 created "2016-06-24" @default.
• W2051557900 creator A5006520799 @default.
• W2051557900 creator A5022471130 @default.
• W2051557900 creator A5023696054 @default.
• W2051557900 creator A5029971128 @default.
• W2051557900 creator A5039723910 @default.
• W2051557900 creator A5043711745 @default.
• W2051557900 creator A5051548699 @default.
• W2051557900 creator A5063848860 @default.
• W2051557900 creator A5067382017 @default.
• W2051557900 creator A5068629247 @default.
• W2051557900 creator A5075427235 @default.
• W2051557900 creator A5083502971 @default.
• W2051557900 creator A5088143804 @default.
• W2051557900 date "2007-05-01" @default.
• W2051557900 modified "2023-10-18" @default.
• W2051557900 title "Risk of Major Bleeding with Concomitant Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients Receiving Long-Term Warfarin Therapy" @default.
• W2051557900 cites W1966920686 @default.
• W2051557900 cites W1969089883 @default.
• W2051557900 cites W1969606544 @default.
• W2051557900 cites W2041726140 @default.
• W2051557900 cites W2053379248 @default.
• W2051557900 cites W2069049455 @default.
• W2051557900 cites W2084005748 @default.
• W2051557900 cites W2084210046 @default.
• W2051557900 cites W2084673482 @default.
• W2051557900 cites W2121047179 @default.
• W2051557900 cites W2139891259 @default.
• W2051557900 cites W2141192690 @default.
• W2051557900 cites W2159193915 @default.
• W2051557900 cites W2327850977 @default.
• W2051557900 cites W2329490408 @default.
• W2051557900 cites W4376848313 @default.
• W2051557900 doi "https://doi.org/10.1592/phco.27.5.691" @default.
• W2051557900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17461704" @default.
• W2051557900 hasPublicationYear "2007" @default.
• W2051557900 type Work @default.
• W2051557900 sameAs 2051557900 @default.
• W2051557900 citedByCount "89" @default.
• W2051557900 countsByYear W20515579002012 @default.
• W2051557900 countsByYear W20515579002013 @default.
• W2051557900 countsByYear W20515579002014 @default.
• W2051557900 countsByYear W20515579002015 @default.
• W2051557900 countsByYear W20515579002016 @default.
• W2051557900 countsByYear W20515579002017 @default.
• W2051557900 countsByYear W20515579002018 @default.
• W2051557900 countsByYear W20515579002019 @default.
• W2051557900 crossrefType "journal-article" @default.
• W2051557900 hasAuthorship W2051557900A5006520799 @default.
• W2051557900 hasAuthorship W2051557900A5022471130 @default.
• W2051557900 hasAuthorship W2051557900A5023696054 @default.
• W2051557900 hasAuthorship W2051557900A5029971128 @default.
• W2051557900 hasAuthorship W2051557900A5039723910 @default.
• W2051557900 hasAuthorship W2051557900A5043711745 @default.
• W2051557900 hasAuthorship W2051557900A5051548699 @default.
• W2051557900 hasAuthorship W2051557900A5063848860 @default.
• W2051557900 hasAuthorship W2051557900A5067382017 @default.
• W2051557900 hasAuthorship W2051557900A5068629247 @default.
• W2051557900 hasAuthorship W2051557900A5075427235 @default.
• W2051557900 hasAuthorship W2051557900A5083502971 @default.
• W2051557900 hasAuthorship W2051557900A5088143804 @default.
• W2051557900 hasConcept C126322002 @default.
• W2051557900 hasConcept C141071460 @default.
• W2051557900 hasConcept C156957248 @default.
• W2051557900 hasConcept C167135981 @default.
• W2051557900 hasConcept C207103383 @default.
• W2051557900 hasConcept C2776301958 @default.
• W2051557900 hasConcept C2777628954 @default.
• W2051557900 hasConcept C2777849778 @default.
• W2051557900 hasConcept C2778205648 @default.
• W2051557900 hasConcept C2779161974 @default.
• W2051557900 hasConcept C2779384505 @default.
• W2051557900 hasConcept C2780400711 @default.
• W2051557900 hasConcept C44249647 @default.
• W2051557900 hasConcept C45393284 @default.
• W2051557900 hasConcept C500558357 @default.
• W2051557900 hasConcept C71924100 @default.
• W2051557900 hasConceptScore W2051557900C126322002 @default.
• W2051557900 hasConceptScore W2051557900C141071460 @default.
• W2051557900 hasConceptScore W2051557900C156957248 @default.
• W2051557900 hasConceptScore W2051557900C167135981 @default.
• W2051557900 hasConceptScore W2051557900C207103383 @default.
• W2051557900 hasConceptScore W2051557900C2776301958 @default.
• W2051557900 hasConceptScore W2051557900C2777628954 @default.
• W2051557900 hasConceptScore W2051557900C2777849778 @default.
• W2051557900 hasConceptScore W2051557900C2778205648 @default.
• W2051557900 hasConceptScore W2051557900C2779161974 @default.
• W2051557900 hasConceptScore W2051557900C2779384505 @default.
• W2051557900 hasConceptScore W2051557900C2780400711 @default.
• W2051557900 hasConceptScore W2051557900C44249647 @default.
• W2051557900 hasConceptScore W2051557900C45393284 @default.
• W2051557900 hasConceptScore W2051557900C500558357 @default.
• W2051557900 hasConceptScore W2051557900C71924100 @default.
• W2051557900 hasIssue "5" @default.
• W2051557900 hasLocation W20515579001 @default.
• W2051557900 hasLocation W20515579002 @default.
• W2051557900 hasOpenAccess W2051557900 @default.

• next